Domperidone (R33812)

Alias:
Cat No.:V1262 Purity: ≥98%
Domperidone (R 33812; R-33812; KW5338; KW-5338; Motilium; Domperidona) is an orally bioactive dopamine D2 receptor antagonist and an antiemetic medication used to relieve nausea and vomiting.
Domperidone (R33812) Chemical Structure CAS No.: 57808-66-9
Product category: Dopamine Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
50mg
100mg
250mg
500mg
1g
2g
Other Sizes

Other Forms of Domperidone (R33812):

  • Domperidone monomaleate
  • Domperidone-d6 (Domperidone d6)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Domperidone (R 33812; R-33812; KW5338; KW-5338; Motilium; Domperidona) is an orally bioactive dopamine D2 receptor antagonist and an antiemetic medication used to relieve nausea and vomiting. It also functions as a galactagogue and a gastric prokinetic agent. Because it is more tolerable than metoclopramide, domperidone is a good substitute for it in the treatment of gastroparesis. In Madin-Darby bovine kidney (MDBK) cells, the D2R antagonist domeperidone inhibits Equilibrative NT1 (ENT1) activity more when bromocriptine is present than when it is not, and it has a lower IC50 value than both of these drugs.

Biological Activity I Assay Protocols (From Reference)
Targets
Dopamine D2 receptor
ln Vitro

In vitro activity: Domperidone (a D2R antagonist) inhibits Equilibrative NT1 (ENT1) activity more when bromocriptine is present than when it is not, and it has a lower IC50 value than both of these drugs in Madin-Darby bovine kidney (MDBK) cells.[1]

ln Vivo
Domperidone (0.1 mg/kg) significantly reduces feeding behavior and increases basal metabolism, but it has no effect on locomotor activity in ats housed in a Phenomaster system.[2] Domperidone (1.1 mg/kg and 5.5 mg/kg, oral) dramatically raises laminar microvascular blood flow (LMBF) in horses starting 4 hours after administration and keeps the effect going for at least 8 hours. This is in comparison with baseline values. When administered intravenously at a dose of 0.2 mg/kg, doperidone dramatically raises laminar microvascular blood flow (LMBF) in horses at 10 and 12 hours after baseline.[3] Domperidone can lessen the negative effects on reproduction and decrease weight gain in heifers affected by fescue toxicosis. [4] Compared to control mares, mares treated with domeperidone had shorter gestations and foaled closer to their anticipated parturition date. Mares receiving dopamine treatment have greater serum prolactin concentrations and Mammary gland scores. [5] In rats, dopamine (5 mg/kg, oral) increases the area under the curve and peak plasma acetaminophen concentration, suggesting enhanced gastric emptying. Domperidone reduces the rat midjejunal longitudinal muscle strips' dopamine-induced contractile activity.[6]
Animal Protocol
1.1 mg/kg and 5.5 mg/kg, oral
Rats
References

[1]. J Agric Food Chem . 2011 Sep 14;59(17):9691-9

[2]. Bull Exp Biol Med . 2013 Oct;155(6):705-7.

[3]. Am J Vet Res . 2010 Mar;71(3):281-7.

[4]. J Anim Sci . 2003 Oct;81(10):2568-74.

[5]. Am J Vet Res . 1994 May;55(5):722-9.

[6]. Am J Vet Res . 2013 Aug;74(8):1103-10.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C22H24CLN5O2
Molecular Weight
425.91
Exact Mass
425.16
Elemental Analysis
C, 62.04; H, 5.68; Cl, 8.32; N, 16.44; O, 7.51
CAS #
57808-66-9
Related CAS #
Domperidone monomaleate; 83898-65-1; Domperidone-d6; 1329614-18-7
Appearance
Solid powder
SMILES
C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O
InChi Key
FGXWKSZFVQUSTL-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30)
Chemical Name
6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one
Synonyms

KW 5338; Domperidone; KW5338; KW-5338; Motilium; Domperidona

HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 48~50 mg/mL (112.7~117.4 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.75 mg/mL (6.46 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.75 mg/mL (6.46 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: ≥ 2.75 mg/mL (6.46 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.


 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3479 mL 11.7396 mL 23.4791 mL
5 mM 0.4696 mL 2.3479 mL 4.6958 mL
10 mM 0.2348 mL 1.1740 mL 2.3479 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT06171087 Recruiting Drug: Domperidon
Drug: Placebo
Emotions German Institute of Human
Nutrition
August 1, 2023 Phase 4
NCT01696734 Recruiting Drug: Domperidone
Other: Questionnaire Administration
Dyspepsia
Esophagitis
Gastroparesis
M.D. Anderson Cancer Center October 23, 2012 Phase 3
NCT04699591 Recruiting Drug: Domperidone GERD
Gastroparesis
Gastroesophageal Reflux
Children's Mercy Hospital
Kansas City
April 2013 Not Applicable
NCT03221855 Completed Drug: Placebo
Drug: Domperidone
Breastfeeding Hospital de Clinicas de Porto
Alegre
March 2013 Early Phase 1
NCT03617016 Completed Drug: Placebo
Drug: Domperidone
Dyspepsia Xian-Janssen Pharmaceutical
Ltd.
August 27, 2018 Phase 4
Biological Data
  • Mean ± SD plasma acetaminophen concentration determined during an acetaminophen absorption test in 2 groups of 6 horses that were administered domperidone paste (1.1 [A] or 5.0 mg [B] of domperidone/kg; circles) or placebo paste (rectangles) orally (2 treatments/horse) and subsequently received oral administration of acetaminophen (20 mg/kg). Am J Vet Res . 2013 Aug;74(8):1103-10.
  • Effect of dopamine solution on isolated strips of longitudinal smooth muscle obtained from the midjejunum of 6 horses that were euthanized for reasons other than gastrointestinal or other systemic disease after the muscle strips were preincubated with domperidone solution (10−4M; circles) or vehicle solution (rectangles) for 20 minutes. Am J Vet Res . 2013 Aug;74(8):1103-10.
Contact Us Back to top